Navigation Links
Hospira Receives FDA Approval for Azithromycin for Injection
Date:6/29/2009

LAKE FOREST, Ill., June 29 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today announced it has received U.S. Food and Drug Administration (FDA) approval for a 500 mg vial of azithromycin for injection in the ADD-Vantage(R) System. The anti-infective medication is a generic version of Pfizer's Zithromax(R) for injection. U.S. sales of generic and name-brand azithromycin for injection were approximately $40 million in 2008.

ADD-Vantage is a specially-designed, two-part system that does not require clinicians to use a needle and syringe to mix the drug and the solution. This reduces the risk of accidental needlesticks, enhances workflow and can result in less waste due to stability and shelf-life factors.

"Hospira is the first company to offer azithromycin in an advanced drug delivery system," said Joshua Gordon, vice president, Specialty Pharmaceuticals, Hospira. "This reinforces Hospira's commitment to healthcare worker safety, as well as to providing safe and effective generic drugs to patients."

Hospira's specialty injectable pharmaceuticals (SIP) offering includes approximately 200 generic injectable drugs in many dosages and formulations. In addition, many of its products are available in popular differentiated formats, several of which are proprietary, such as its ADD-Vantage System and iSecure(R) prefilled syringes. Therapeutic areas include anesthesia, anti-infectives, analgesics, cardiovascular, oncology, emergency and other areas. Hospira has approximately 25 generic drugs scheduled to launch in various regions around the world in 2009 and 2010.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has more than 14,000 employees. Learn more at www.hospira.com.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Hospira to Host Conference Call for Second-Quarter 2009 Results
2. Hospira Highlights Five Years of Progress and Future Opportunities at Its 2009 Annual Meeting of Shareholders
3. Hospira to Present at Bank of America and Merrill Lynch 2009 Health Care Conference May 13
4. Hospira Launches Biologics Clock and Web Resource to Raise Awareness of Potential Biogenerics Impact
5. Hospira Reports First-Quarter 2009 Results
6. Hospira to Host Conference Call for First-Quarter 2009 Results
7. Hospira to Present at Cowen and Companys 29th Annual Health Care Conference March 17
8. Hospira Expands Board of Directors
9. Hospira Reports Fourth-Quarter and Full-Year 2008 Results
10. Hospiras Precedex(R) Phase IV Study Published in the Journal of the American Medical Association
11. Hospira to Host Conference Call for Fourth-Quarter 2008 Results and 2009 Projections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... ... “Our Mountains to Climb: A Journey of Love and Faith Through Trials”: ... the faith they shared to overcome struggles in life. “Our Mountains to Climb: A ... J. Corcoran, a retired teacher and happily married since 1999; the author’s personal experiences ...
(Date:8/18/2017)... , ... August 18, 2017 , ... ... marketers of high-quality anti-aging skincare solutions, recently announced the launch of ... products are an affordable, yet effective alternative to expensive plastic surgery or in-patient ...
(Date:8/17/2017)... ... August 17, 2017 , ... Riccobene Associates Family Dentistry, ... Goldsboro, NC to its family of practices. Residents of Goldsboro will be able ... 15, 2017. , Riccobene Associates Family Dentistry, founded by Dr. Michael Riccobene ...
(Date:8/17/2017)... ... August 17, 2017 , ... ... of three years for its residential drug and alcohol detox program. This accreditation ... organization and shows the organization’s substantial conformance to the CARF standards. , Behavioral ...
(Date:8/17/2017)... ... August 17, 2017 , ... The 2017 Integrated Delivery ... systems to interact with their GPO and supplier partners. This year, Winifred Hayes, ... System Director of Clinical Value Analytics, have been invited to present “Episode-based Reimbursement ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... 2017 Diplomat Pharmacy, Inc. (NYSE: DPLO), is ... residents. Naloxone is available without ... retail pharmacy, G-3320 Beecher Road. ... Drug Administration, is intended to block or reverse the ... loss of consciousness. The medication is often carried by ...
(Date:8/11/2017)... -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... today announced that it will release its second quarter ... conference call at 9:00am ET. The Company will discuss ... its strategy and outlook for the remainder of 2017. The ... , Chief Executive Officer, and Zvi Ben-David , ...
(Date:8/7/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... its Board of Directors has approved the payment of a ... 2017. The cash dividend ... October 27, 2017 to stockholders of record as of the ... dividends are subject to approval of the Board of Directors ...
Breaking Medicine Technology: